Cargando…
An immunotherapeutic approach to decipher the role of long non-coding RNAs in cancer progression, resistance and epigenetic regulation of immune cells
Immunotherapeutic treatments are gaining attention due to their effective anti-tumor response. Particularly, the revolution of immune checkpoint inhibitors (ICIs) produces promising outcomes for various cancer types. However, the usage of immunotherapy is limited due to its low response rate, sugges...
Autores principales: | Varier, Krishnapriya M., Dhandapani, Hemavathi, Liu, Wuling, Song, Jialei, Wang, Chunlin, Hu, Anling, Ben-David, Yaacov, Shen, Xiangchun, Li, Yanmei, Gajendran, Babu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305593/ https://www.ncbi.nlm.nih.gov/pubmed/34303380 http://dx.doi.org/10.1186/s13046-021-01997-5 |
Ejemplares similares
-
UM171 cooperates with PIM1 inhibitors to restrict HSC expansion markers and suppress leukemia progression
por: Hu, Anling, et al.
Publicado: (2022) -
A C21-steroidal derivative suppresses T-cell lymphoma in mice by inhibiting SIRT3 via SAP18-SIN3
por: Gajendran, Babu, et al.
Publicado: (2020) -
FLI1 Induces Megakaryopoiesis Gene Expression Through WAS/WIP-Dependent and Independent Mechanisms; Implications for Wiskott-Aldrich Syndrome
por: Wang, Chunlin, et al.
Publicado: (2021) -
ERK activation via A1542/3 limonoids attenuates erythroleukemia through transcriptional stimulation of cholesterol biosynthesis genes
por: Yu, Fang, et al.
Publicado: (2021) -
FLI1 Regulates Histamine Decarboxylase Expression to Control Inflammation Signaling and Leukemia Progression
por: Hu, Jifen, et al.
Publicado: (2023)